Burjeel, Avatrial partner to develop first-of-its-kind AI-powered cancer drug discovery ecosystem in Abu Dhabi
ABU DHABI, 20th October, 2026 (WAM) -- Burjeel Holdings has signed a Memorandum of Understanding (MoU) with Avatrial, a UK-based biotechnology company, to explore the development of a first-of-its-kind integrated AI-powered cancer drug discovery ecosystem in Abu Dhabi. The MoU was signed at the Abu Dhabi Future Health Summit in the presence of Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings.
Prof. Kha
Read the full report on Bignewsnetwork
Story file
- Section
- Sports
- Topics
- AI & gadgets, Health alerts
- First reported by
- Bignewsnetwork
- Published
- Tuesday, 20 October 2026, 9:24 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Bignewsnetwork with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.
